Medical Nutrition Therapy (MNT) in Adult Oncology Patients

Medical Nutrition Therapy is a systematic approach that uses nutrition assessment, diagnosis, intervention, and monitoring to help patients manage the metabolic challenges of cancer and its treatment. In adult oncology, MNT supports treatment tolerance, maintains lean body mass, reduces infection risk, and improves quality of life.

Why Nutrition Matters in Cancer Care

• Metabolic alterations: Tumors can cause hypermetabolism, increased protein catabolism, and altered glucose handling.
• Treatment sideeffects: Surgery, chemotherapy, radiation, and immunotherapy frequently produce nausea, vomiting, mucositis, dysphagia, taste changes, diarrhea, or constipation.
• Weight loss and cachexia: Unintentional weight loss >5% in 6 months is linked to poorer survival and functional decline.
• Immune function: Adequate protein and micronutrients are essential for wound healing and infection control.

Key Components of Oncology MNT

1. Nutrition Assessment

Comprehensive assessment should be performed at diagnosis and reassessed regularly (every 24 weeks during active treatment).

2. Nutrition Diagnosis

Common diagnoses (per the Nutrition Care Process) include:

• Inadequate energy intake related to chemotherapyinduced nausea.
• Proteinenergy malnutrition related to tumorinduced catabolism.
• Deficient oral intake related to mucositis.
• Electrolyte imbalance related to diuretic therapy.

3. Nutrition Intervention

Interventions are individualized, but the following strategies are widely applicable.

Energy and Protein Requirements

• Energy: 2530 kcal/kg body weight/day (adjust for hypermetabolism).
• Protein: 1.22.0 g/kg body weight/day; higher (up to 2.5 g/kg) for those with severe catabolism or undergoing major surgery.

Route of Nutrition Delivery

• Oral diet: Preferred when safe. Use highdensity foods, fortified smoothies, and oral nutritional supplements (ONS). Aim for 23 servings of ONS per day if intake <75% of needs.
• Enteral nutrition (EN): Indicated when oral intake <60% of needs for >57 days and GI tract is functional. Nasogastric or percutaneous endoscopic gastrostomy tubes are common.
• Parenteral nutrition (PN): Reserved for patients with nonfunctional GI tract or severe malabsorption when EN is contraindicated.

SymptomTargeted Strategies

• Nausea/vomiting: Small, frequent meals; bland foods; ginger; antiemetic timing with meals.
• Mucositis: Soft, nonabrasive foods; avoid acidic/spicy items; mouth rinses; use of highprotein, lowresidue ONS.
• Diarrhea: Lowfiber, lowfat diet; consider Lactobacilluscontaining probiotic; rehydration with electrolyte solutions.
• Constipation: Highfiber foods, adequate fluids, stool softeners if needed.
• Taste changes: Use herbs, marinades, temperature contrast, flavor enhancers.

Micronutrient Considerations

Routine highdose supplementation is not recommended unless a deficiency is documented.

• Vitamin D: 8002000 IU/day if serum 25OHD <30 ng/mL.
• Iron: Oral ferrous sulfate or IV iron if anemia with iron deficiency.
• Folate & B12: Important for patients on methotrexate or with malabsorption.

Special Populations

• Head & neck cancer: Early referral for EN; use of thickened liquids; speechlanguage pathology involvement.
• Gastrointestinal malignancies: Monitor for short bowel syndrome; consider elemental formulas.
• Hematologic cancers: Manage neutropenic diet cautiously; focus on food safety rather than complete restriction.

4. Monitoring and Evaluation

Key indicators to track weekly or biweekly:

• Weight change (goal: <1% loss per week).
• Oral intake (% of estimated needs).
• Laboratory markers (albumin, prealbumin, CRP).
• Functional status (handgrip strength, performance scales).
• Symptom scores (e.g., MD Anderson Symptom Inventory).

Adjust the nutrition plan based on trends. Successful outcomes include weight stability or gain, improved protein status, and reduced treatment interruptions due to nutritionrelated complications.

Interdisciplinary Collaboration

Effective oncology MNT requires coordinated care among dietitians, oncologists, nurses, pharmacists, and supportivecare teams.

• Regular tumor board meetings to discuss nutrition status.
• Education sessions for patients and caregivers on managing side effects.
• Integration of nutrition goals into electronic health records for continuity.

Evidence Highlights

Recent systematic reviews (20202024) show that structured MNT reduces the risk of severe weight loss by 3040% and improves chemotherapy tolerance by up to 25%. Early nutrition counseling (within 2 weeks of diagnosis) is associated with higher completion rates of curative treatment regimens.

Conclusion

Medical Nutrition Therapy is an essential component of comprehensive cancer care. By systematically assessing, diagnosing, intervening, and monitoring nutrition status, clinicians can mitigate treatmentrelated toxicities, preserve functional capacity, and support better clinical outcomes for adult oncology patients.